[Prognostic factors and remote results in operated patients with non-small cell lung cancer in I clinical stage].
The non-small lung cancer is a leader for currency and mortality among the oncological diseases. In this moment the surgical resection is a standard in the treatment of patients in initial disease stages. The aim of present announcement is to share of our distant results in the operative treatment of patients in first clinical stages. We examine the most important prognostic factors. We investigate 49 patients in our study in first clinical stages with a non-small cell lung cancer. All of them are surgically treated. The five year survival is 71% in the patients in 1A stage and 58% in these in 1B stage. Operative treatment in the cases with non-small cell lung cancer in first clinical stage leads to good results. The tumor size and surgical intervention volume are significant for a distant survival.